Patents by Inventor Benjamin Christensen

Benjamin Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6143782
    Abstract: This invention relates to a method for selecting PDE IV inhibitors which have a salutory therapeutic index, and to compounds having these properties.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: November 7, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Mary S. Barnette, Theodore J. Torphy, Siegfried Benjamin Christensen, IV
  • Patent number: 6100259
    Abstract: Novel pyrazole derivatives are provided which are cannabinoid receptor modulators.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: August 8, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Jia-Ning Xiang, John Duncan Elliott, Steven Todd Atkinson, Siegfried Benjamin Christensen, IV
  • Patent number: 5998428
    Abstract: This invention relates to a method for selecting PDE IV inhibitors which have a salutory therapeutic index, and to compounds having these properties.
    Type: Grant
    Filed: September 3, 1997
    Date of Patent: December 7, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Mary S. Barnette, Theodore J. Torphy, Siegfried Benjamin Christensen, IV
  • Patent number: 5948777
    Abstract: Novel pyrazole derivatives are provided which are cannabinoid receptor agonists.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: September 7, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Paul Elliot Bender, Siegfried Benjamin Christensen, IV
  • Patent number: 5811455
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: September 22, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Siegfried Benjamin Christensen, IV, Paul Elliot Bender, Cornelia Jutta Forster
  • Patent number: 5780667
    Abstract: Novel cyclohexane derivatives of Formula (I) ##STR1## are described herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production; they are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in the treatment of disease states in need of mediation or inhibition thereof.
    Type: Grant
    Filed: May 27, 1996
    Date of Patent: July 14, 1998
    Assignee: SmithKline Beecham Corporation
    Inventor: Siegfried Benjamin Christensen, IV
  • Patent number: 5643946
    Abstract: Compounds of the formula ##STR1## wherein the substituents are as defined herein, are disclosed. Pharmaceutical compositions and methods of treating allergic and inflammatory diseases are also taught.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: July 1, 1997
    Assignee: SmithKline Beecham Corporation
    Inventor: Siegfried Benjamin Christensen, IV